Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.
The discovery of this novel compound challenges long-held scientific beliefs and holds great promise for treating an array of menacing infections, says Northeastern University Distinguished Professor Kim Lewis.
University Distinguished Professor of Biology Kim Lewis is exploring alternative approaches to curing chronic Lyme disease using his expertise in bacterial cell persistence.
I hope you caught a glimpse of our interview with Betsy Hirsch on Tuesday on the impact of antibiotic resistant bacteria on national health. Bottom line: resistance is no good. […]
The Centers for Disease Control and Prevention recently released a new report on the impact of antibiotic resistant bacteria on national health. We asked assistant professor Betsy Hirsch to explain its significance and what it means for the public.
In recent years, the notion that there is a single mechanism by which antibiotics wipe out bacteria has permeated the field of microbiology. Now, new research from professor Kim Lewis and his team questions that hypothesis.
Last week I went to an interesting event hosted by Northeastern’s College of Engineering that opened my eyes a little wider to the problem of biofilms. These are colonies of bacterial […]
Persistence — it’s what keeps us all surviving. If it weren’t for this lovely quality, we’d just give up and crawl under a rock somewhere because it’s all just so […]
Sepsis is a whole-body inflammatory response to an overwhelming infection by bacteria or other microogransim. At first glance, it may not seem like a big enough issue to dedicate a […]
In collaboration with the J. Craig Ventor Institute, biology professor Slava Epstein will study the roles of microbial species in model bacterial communities of Northern Greenland.
Biology professor Slava Epstein proposes a new theory to explain why some bacteria are so hard to grow in the lab.
In the last fifty years, pharmaceutical companies have spent tens of billions of dollars trying to find new classes of antibiotic drugs. Only one has made it into clinical practice. […]